Other existing investors, such as Warburg Pincus, OrbiMed Advisors, and Lilly Ventures, participated in the funding round for the private company. This investment contributed to the company’s growth and development, highlighting the continued interest and support from notable investors in the healthcare and biotechnology sectors. The involvement of these firms signifies a strong confidence in the company’s potential and future prospects in the industry.